Drug and vaccine stabilisation and delivery are an integral part of the technologies and expertise at AzureBio. Stabilisation of biologicals in solid solutions is a technology learned from "anhydrobiotic" organisms such as the bakers yeast Saccharomyces cerevisiae, resurrection plants Selaginella lepidophylla, or rotifers of the Philodina sp., all of which are capable of surviving complete desiccation in a state of "latent life" that does not require cold storage.

AzureBio has incorporated pharmaceutical developments based on this knowledge in the stabilisation of drugs, vaccines and reagents that not require refrigeration and can be formulated to simplify their use by avoiding recostitution, dilution, or mixing procedures which are normally required.

AzureBio offers its expertise for:

• Formulation of biologicals and small molecules avoiding cold storage
• Enhancing and modifying drug delivery profiles
• Solubilizing and delivering hard to dissolve molecules
• Optimising PCR and ELISA kits
• Optimising drug product manufacture